Clinical utility of lipoprotein (a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease

M Trinder, MM Uddin, P Finneran, KG Aragam… - JAMA …, 2021 - jamanetwork.com
Importance Lipoprotein (a) is a highly heritable biomarker independently associated with
atherosclerotic cardiovascular disease (ASCVD). It is unclear whether measured lipoprotein …
被引用次数：116 相关文章
[HTML] nih.gov

[HTML][HTML] Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease

M Trinder, MM Uddin, P Finneran, KG Aragam… - JAMA …, 2021 - ncbi.nlm.nih.gov
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident
Atherosclerotic Cardiovascular Disease - PMC Back to Top Skip to main content NIH NLM Logo …

Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease

M Trinder, MM Uddin, P Finneran, KG Aragam… - JAMA … - pubmed.ncbi.nlm.nih.gov
Importance Lipoprotein (a) is a highly heritable biomarker independently associated with
atherosclerotic cardiovascular disease (ASCVD). It is unclear whether measured lipoprotein …

Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease.

M Trinder, MM Uddin, P Finneran, KG Aragam… - JAMA …, 2020 - europepmc.org
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident
Atherosclerotic Cardiovascular Disease. - Abstract - Europe PMC Sign in | Create an account …
[PDF] amedeolucente.it

[PDF][PDF] Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease

M Trinder, MM Uddin, P Finneran, KG Aragam… - amedeolucente.it
OBJECTIVE To determine whether a genetic risk score (GRS) comprising 43 variants at the
LPA gene, which encodes apolipoprotein (a), has clinical utility in assessing ASCVD risk …
[PDF] amedeolucente.it

[PDF][PDF] Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease

M Trinder, MM Uddin, P Finneran, KG Aragam… - amedeolucente.it
OBJECTIVE To determine whether a genetic risk score (GRS) comprising 43 variants at the
LPA gene, which encodes apolipoprotein (a), has clinical utility in assessing ASCVD risk …

Clinical Utility of Lipoprotein (a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease.

M Trinder, MM Uddin, P Finneran, KG Aragam… - JAMA …, 2020 - europepmc.org
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident
Atherosclerotic Cardiovascular Disease. - Abstract - Europe PMC Sign in | Create an account …